This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Consejo Superior De Investigaciones Cientificas. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Balbino Jose Alarcon Sanchez: Innovator in Immunosuppressive Compounds
Introduction
Balbino Jose Alarcon Sanchez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of immunosuppressive agents. His work focuses on innovative compounds that have the potential to impact therapeutic strategies in immunology.
Latest Patents
Balbino holds 2 patents that highlight his expertise in chromene derivatives. His latest patents include "Chromene derivatives - Derivates of chromene of formula I," which describes compounds useful as inhibitors of TCR-Nck interaction in T lymphocytes. Another significant patent is "Immunosuppressor based on the blockage of TCR-Nck interaction," which relates to a compound of structural formula (I) and its derivatives for use as medicinal drugs. These compounds are primarily designed to act as immunosuppressive agents, utilizing a mechanism of action based on the blockage of TCR-Nck interaction.
Career Highlights
Balbino is affiliated with the Consejo Superior de Investigaciones Científicas, where he conducts his research and development activities. His work has garnered attention for its potential applications in treating various immune-related conditions.
Collaborations
Throughout his career, Balbino has collaborated with esteemed colleagues, including Antonio Morreale De Leon and Aldo Jorge Borroto Revuelta. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Balbino Jose Alarcon Sanchez is a prominent figure in the field of immunology, with a focus on innovative compounds that can serve as immunosuppressive agents. His contributions through patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile